Martha J Demski - Net Worth and Insider Trading
Martha J Demski Net Worth
The estimated net worth of Martha J Demski is at least $217,387 dollars as of 2024-05-15. Martha J Demski is the Director of Adamas Pharmaceuticals Inc and owns about 13,000 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $106,860. Martha J Demski is the Director of Chimerix Inc and owns about 72,055 shares of Chimerix Inc (CMRX) stock worth over $72,055. Martha J Demski is also the Director of ADMA Biologics Inc and owns about 4,200 shares of ADMA Biologics Inc (ADMA) stock worth over $38,472. Details can be seen in Martha J Demski's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Martha J Demski has not made any transactions after 2023-05-10 and currently still holds the listed stock(s).
Transaction Summary of Martha J Demski
Martha J Demski Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Martha J Demski owns 7 companies in total, including ADMA Biologics Inc (ADMA) , Chimerix Inc (CMRX) , and Adamas Pharmaceuticals Inc (ADMS) among others .
Click here to see the complete history of Martha J Demski’s form 4 insider trades.
Insider Ownership Summary of Martha J Demski
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADMA | ADMA Biologics Inc | 2022-03-07 | director |
| CMRX | Chimerix Inc | 2023-05-10 | director |
| ADMS | Adamas Pharmaceuticals Inc | 2020-06-03 | director |
 | | 2018-10-11 | director |
| | 2014-11-19 | director |
| | 2004-05-21 | Vice President & CFO |
| | 2023-08-31 | director |
Martha J Demski Latest Holdings Summary
Martha J Demski currently owns a total of 3 stocks. Among these stocks, Martha J Demski owns 13,000 shares of Adamas Pharmaceuticals Inc (ADMS) as of April 9, 2014, with a value of $106,860 and a weighting of 49.16%. Martha J Demski owns 72,055 shares of Chimerix Inc (CMRX) as of May 10, 2023, with a value of $72,055 and a weighting of 33.15%. Martha J Demski also owns 4,200 shares of ADMA Biologics Inc (ADMA) as of September 11, 2020, with a value of $38,472 and a weighting of 17.7%.
Latest Holdings of Martha J Demski
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2014-04-09 | 13,000 | 8.22 | 106,860 |
| CMRX | Chimerix Inc | 2023-05-10 | 72,055 | 1.00 | 72,055 |
| ADMA | ADMA Biologics Inc | 2020-09-11 | 4,200 | 9.16 | 38,472 |
Holding Weightings of Martha J Demski
Martha J Demski Form 4 Trading Tracker
According to the SEC Form 4 filings, Martha J Demski has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 0 shares on April 9, 2014, which brought Martha J Demski around $0.
According to the SEC Form 4 filings, Martha J Demski has made a total of 6 transactions in Chimerix Inc (CMRX) over the past 5 years, including 3 buys and 3 sells. The most-recent trade in Chimerix Inc is the acquisition of 18,000 shares on May 10, 2023, which cost Martha J Demski around $19,980.
According to the SEC Form 4 filings, Martha J Demski has made a total of 2 transactions in ADMA Biologics Inc (ADMA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in ADMA Biologics Inc is the acquisition of 2,200 shares on September 11, 2020, which cost Martha J Demski around $5,038.
Insider Trading History of Martha J Demski
- 1
Martha J Demski Trading Performance
GuruFocus tracks the stock performance after each of Martha J Demski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Martha J Demski is -8.26%. GuruFocus also compares Martha J Demski's trading performance to market benchmark return within the same time period. The performance of stocks bought by Martha J Demski within 3 months outperforms 1 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Martha J Demski's insider trading performs compared to the benchmark.
Performance of Martha J Demski
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.67 | | | | | |
| Relative Return to S&P 500(%) | 2.56 | | | | | |
Martha J Demski Ownership Network
Martha J Demski Owned Company Details
What does ADMA Biologics Inc do?
Who are the key executives at ADMA Biologics Inc?
Martha J Demski is the director of ADMA Biologics Inc. Other key executives at ADMA Biologics Inc include director & President and CEO Adam S Grossman , EVP & CFO Brian Lenz , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
ADMA Biologics Inc (ADMA) Insider Trades Summary
Over the past 18 months, Martha J Demski made no insider transaction in ADMA Biologics Inc (ADMA). Other recent insider transactions involving ADMA Biologics Inc (ADMA) include a net sale of 730,507 shares made by Adam S Grossman , a net sale of 1,500,000 shares made by Steve Elms , and a net sale of 382,769 shares made by Brian Lenz .
In summary, during the past 3 months, insiders sold 1,500,000 shares of ADMA Biologics Inc (ADMA) in total and bought 0 shares, with a net sale of 1,500,000 shares. During the past 18 months, 4,083,538 shares of ADMA Biologics Inc (ADMA) were sold and 191,958 shares were bought by its insiders, resulting in a net sale of 3,891,580 shares.
ADMA Biologics Inc (ADMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
ADMA Biologics Inc Insider Transactions
Martha J Demski Mailing Address
Above is the net worth, insider trading, and ownership report for Martha J Demski. You might contact Martha J Demski via mailing address: 7770 Regents Road Suite 113-505, San Diego Ca 92122.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
